previous compound ID: 27 next compound
InChIKey: AUYYCJSJGJYCDS-LBPRGKRZSA-N
SMILES: C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O

biological descriptors:

CFTR relevance: medium CFTR corrector

Category:
Influence on CFTR function enhances CFTR function
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 55
"JW Hanrahan" "D Zhang" "DY Thomas" "Y Luo" "KA Teske" "GW Carlile" "R Robert"
ReferenceID: 53
"B Kus" "J Goepp" "JW Hanrahan" "SD Macknight" "E Matthes" "DY Thomas" "GW Carlile" "R Robert" "J Liao" "D Rotin"

chemical graph of compound 27





CID is 5920
synonyms found at PubChem are:
liothyronine, triiodothyronine, 3,3',5-Triiodo-L-thyronine, 6893-02-3, Liothyronin, Tresitope, 3,5,3'-triiodothyronine, L-Liothyronine, triothyrone, Liothyroninum, Liotironina, 3,5,3'-Triiodo-L-thyronine, L-T3, T3, Triiodo-L-thyronine, Lyothyronine, 3,3',5-Triiodothyronine, O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine, L-3,5,3'-Triiodothyronine, 3,5,3'TRIIODOTHYRONINE, (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid, T3 (amino acid), T3 (Hormone), L-3,3',5-TriioDOThyronine, T3 liothyronine, Liothyronine [INN:BAN], Euthroid-1, Euthroid-2, Euthroid-3, Thyrolar-1, Thyrolar-2, Thyrolar-3, Liotironina [INN-Spanish], Tri-Thyrotope, Euthroid-0.5, Thyrolar-0.5, Liothyronine (INN), T3 (VAN), Triiodothyronine, l-, Thyrolar-0.25, THYROID HORMONE, 3,5,3'-Tri-iodo-L-thyronine, CHEBI:18258, T3 (Triiodothyronine), Triiodothyronine (T3), L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-, Triomet-131, T3 (LIOTRIX), Liothyroninum [INN-Latin], CHEMBL1544, UNII-06LU7C9H1V, 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine, (S)-2-amino-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoic acid, 06LU7C9H1V, 3,3',5-Triiodothyronine, L-, HSDB 3110, Triiodo-thyroninum, AUYYCJSJGJYCDS-LBPRGKRZSA-N, EINECS 229-999-3, MFCD00002593, NSC 80203, 4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine, BRN 2710227, 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine, L-triiodothyronine, L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine, Alanine, 3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-, L-, Cytomel (TN), DSSTox_CID_3216, DSSTox_RID_76928, DSSTox_GSID_23216, TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%), CAS-6893-02-3, SR-05000000455, Cyronine, NSC-46046, C15H12I3NO4, 1xzx, Tertroxin (TN), 5714-08-9, Prestwick_135, PubChem20012, Spectrum_001445, Prestwick0_000853, Prestwick1_000853, Prestwick2_000853, Prestwick3_000853, Spectrum2_001984, Spectrum3_001887, Spectrum4_000326, Spectrum5_001793, T-3, Liothyroninum[INN-Latin], L-T3|||L-Liothyronine, D0D8QI, D0S6JG, Epitope ID:131324, AC1L1LF0, SCHEMBL8300, NCIStruc1_000449, Liothyronine modified release, REGID_for_CID_5920, BSPBio_000865, BSPBio_003394, KBioGR_000671, KBioGR_002568, KBioSS_001925, KBioSS_002577, 3,3'5-Triiodo-L-thyronine, MLS000028458, 3,5,3'-triodo-L-thyronine, SPBio_002167, SPBio_002786, BPBio1_000953, GTPL2634, L-3,3',5-triiodo-Thyronine, 3,3',5-Trichloro-L-thyromine, 3,3\',5-triiodo-L-thyronine, DTXSID8023216, BCBcMAP01_000192, BDBM18860, CTK1A2555, HY-A0070A, KBio2_001925, KBio2_002568, KBio2_004493, KBio2_005136, KBio2_007061, KBio2_007704, KBio3_002897, KBio3_003046, (2R)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid, cMAP_000088, MolPort-003-850-717, HMS1570L07, HMS2097L07, HMS2235A22, HMS3714L07, ZINC3830999, Tox21_110029, Tox21_301943, ANW-60592, CT-833, NCGC00013556, 3,5,3'-triiodo-L-thyronine (T3), Thyronine, 3,3',5-triiodo-, L-, AKOS016003266, 3,3',5-Triiodo-L-thyronine, 95%, AM83597, CCG-220853, CS-4141, DB00279, SMP1_000179, NCGC00013556-01, NCGC00013556-02, NCGC00013556-03, NCGC00013556-04, NCGC00096669-01, NCGC00096669-02, NCGC00255336-01, [125I]T3, AS-17446, KB-28438, KB-99685, LS-16137, SC-11044, SMR000058402, SBI-0206718.P001, DB-021796, Thyronine, 3,3',5-triiodo-, L-(6CI), TR-031350, Thyronine, 3,3',5-triiodo-, L- (6CI), C02465, D08128, 893T023, SR-01000003143, SR-01000003143-4, SR-05000000455-2, SR-05000000455-3, 3,5,3 inverted exclamation marka-Triiodo-L-thyronine, BRD-K89152108-001-03-3, 3,3',5-Triiodo-L-thyronine, >=95% (HPLC), powder, Z2216208625, L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-(9CI), UNII-O48UO55HR0 component AUYYCJSJGJYCDS-LBPRGKRZSA-N, L-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]-Alanine, L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo- (9CI), Liothyronine, United States Pharmacopeia (USP) Reference Standard, 3,3',5 Triiodothyronine (T3), IRMM(R) certified Reference Material, (2S)-2-AMINO-3-[4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]PROPANOIC ACID, (S)-2-Amino-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoicacid, Liothyronine, Pharmaceutical Secondary Standard; Certified Reference Material, 3,3',5-Triiodo-L-thyronine (T3) solution, 100 mug/mL in methanol with 0.1N NH3, ampule of 1 mL, certified reference material, 57164-27-9, 7013-53-8, (2S)-2-azaniumyl-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoate, AC1OFCLR, CHEBI:533015, 3,3',5-triiodo-L-thyronine zwitterion, 4-(3-iodo-4-hydroxy-phenoxy)-3,5-diiodophenylalanine, (S)-2-Amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]-propionic acid